TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change from Baseline to Week 12 in Aberrant Behavior Checklist (ABC)
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Change from Baseline to Week 12 in Autism Treatment Evaluation Checklist (ATEC)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in distress on Glasgow Depression Scale (GDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in distress on Anxiety Depression and Mood Scale (ADAMS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of Fatal Overdose
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Non-Fatal Overdose
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Psychiatric Services Utilization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Delivered UFnet rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No. of participants with protocol deviation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Participant recruitment rate over 21 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: DD-cfDNA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of maternal participants with solicited administration site events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of maternal participants with solicited systemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of maternal participants with unsolicited adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of maternal participants with serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of maternal participants with pregnancy outcomes
Endpoint domain: Physiological/clinical
Primary endpoint: Percentage of maternal participants with pregnancy-related adverse events of special interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Neck Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Upper Back Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Immediate lumen acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of lumbar disc MRI (T2WI) signal values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic Measurements of bilateral knees
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: events of injury
Endpoint domain: Adverse events/effects
Primary endpoint: time efficiency
Endpoint domain: Resource use
Primary endpoint: subjective estimation of safety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Liver decompensation prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Safety of the adoptive T regs transfer
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of the adoptive T regs transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of muscularis mucosa included in specimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preparation of tumor organoid cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Difference in response between intervention and control arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CE in women with idiopathic infertility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cut-off point of the number of plasma cells/1 mm2 defining CE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periprosthetic joint infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change of left ventricular ejection fraction (LVEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in relative abundance of combined vaginal lactobacilli species
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in incremental glucose peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in mean amplitude of glycemic excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in time in range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Kinesiophobia Causes Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional assessment of chronic illness therapy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lymphedema Quality of Life Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sensitivity of postoperative ctDNA methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of postoperative ctDNA methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of postoperative ctDNA methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal congenital malformation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Intellectual development of 1-year-old children
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Recurrence of vHSIL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Recommended Phase 2 Dose (RP2D) and/or maximum tolerated dose (MTD)
Endpoint domain: Adverse events/effects
Primary endpoint: Orthosis wearing time (sensor measured)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orthosis wearing time (self-reported)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants Who Achieve Functional Cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Alpha Diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Microbial Gene Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic proteome profiling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of NUV-868
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline in Tumor Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in PSA measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from First Dose to Disease Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to Study Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Food insecurity level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dose-limiting toxicity (DLT) at the maximum tolerated dose (MTD)
Endpoint domain: Adverse events/effects
Primary endpoint: Dose limiting toxicity (DLT) for the DEC Phase
Endpoint domain: Adverse events/effects
Primary endpoint: Self -Reflection and Insight Scale (SRIS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Buffalo Vocational Monitoring Survey (BVMS)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: The Valued Living Questionnaire (VLQ)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Body balance analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body posture analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: X-ray analysis in frontal plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: X-ray analysis in sagittal plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DLTs (dose-limiting toxicity)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of safety event
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of safety event
Endpoint domain: Adverse events/effects
Primary endpoint: Termination of resuscitation practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linkage to MOUD Care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Breast cancer screening attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Kinematics of the spine during walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinematics of the spine during bending forward and lifting objects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinematics of the spine during standing from sitting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinematics of the spine during climbing step
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain of shoulder as measured by the ASES
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional limitations of shoulder as measured by the SST
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in strength of shoulder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brief Pain Inventory (BPI) Pain Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute thoracic pain during cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients proceeding to GCT consultation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Occurrence of secondary infections
Endpoint domain: Adverse events/effects
Primary endpoint: quick SEPSIS RELATED ORGAN FAILURE ASSESSMENT (qSOFA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Limb volume reduction or maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LYMQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Therapy adherence tracking
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean level of serum uric acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Score Short Form Health Survey (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Physical and Psychological Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Workload
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Occurrence of intraoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of interventions to cure intraoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total Time under hypotension thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Evoked Potentials (MEPs) in Ankle Dorsiflexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: preoperative perfusion parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desires and needs for weight loss
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skin Conductance Response (SCR) during the image familiarization phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin Conductance Response (SCR) during the fear conditioning phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who had higher event-related potentials (ERPs) in response to CS+ categories relative to CS- categories during the image familiarization phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy in treating acute vaginal infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reproducibility of qDCE-MRI measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differentiation between pseudo- and true-progressions of glioblastoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with treatment related adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity and specificity of MCG scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants having successfully stopped benzodiazepine use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 6 months endoscopic recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Feasibility of the QoR 15
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants who develop deep surgical site infection (SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of Epileptic syndromes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in immediate and delayed free recall Auditory Verbal Learning Test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in immediate free recall and delayed recognition Face-Name Memory Test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Plasma Nitrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Urine Nitrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Right ventricular strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of auditory hallucinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distress of auditory hallucinations
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prognostic indicators of Guillain-Barre syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility - Accrual Rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention Over Time (From Baseline to Post-assessment)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Detected white- and grey-matter lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Oxygen consumption (VO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma concentrations of brexpiprazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restoration of menstrual regularity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Chemotherapy Relative Dose Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haemostatic effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation coefficient between eCochG trauma index and residual hearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of measurement methods in diagnosing unilateral and bilateral LLL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of measurement methods in diagnosing unilateral and bilateral LLL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of measurement methods in diagnosing unilateral and bilateral LLL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentile of cases with increased diaphragm thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in patient asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in respiratory health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oropharyngeal Leak Pressure (OLP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf (Area under plasma concentration-time curve from time zero to infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast (Area under the plasma concentration-time curve from zero to time of last quantifiable concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient subjective outcome measures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurence of Progression Independent of Relapse Activity (PIRA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neuroaxonal loss in the retina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neuroinflammation in the retina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of responding eyes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Satisfaction among Participants
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical performance of CAD-CAM onlay restorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in chair rise time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duke Activity Status Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: pFTOE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodynamic Variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Obstructive Apnea Hypopnea Index (OAHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: SaO2-SpO2 discrepancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportions of S. pneumoniae serotypes included in PCV20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Treatment-Emergent Adverse Events (NCI-CTCAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Treatment-Emergent Adverse Events (Clinical Laboratory Measurements)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Treatment-Emergent Adverse Events (Neurological Examination)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Pain as measured by the visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sensation measured by Electrical sensation detection threshold (EDT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Heart Rate Variability (HRV) measured by electrocardiogram (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Toxicities Grade 3 or Above Related to Therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Disease Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean changes in CAT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: feasibility of motorized PowerSpiral enteroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety of motorized PowerSpiral enteroscopy
Endpoint domain: Adverse events/effects
Primary endpoint: Visual analog scale (VAS) pain Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of ischaemic lesions on brain MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Muscle spasticity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elbow range of motion changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall incidence of grade 2 or 3 CIPN
Endpoint domain: Adverse events/effects
Primary endpoint: Healing time of stage 1 and 2 pressure injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV-specific IgG binding magnitude to cross-clade panels of gp120 and V1V2, and gp41
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response rate of CD4+ T-cell responses to Env
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maximum tolerated dose (MTD) of ADG 206
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of vaccine side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Successful pump refill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician safety
Endpoint domain: Adverse events/effects
Primary endpoint: EER severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EER type
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: allergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes